BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 8045490)

  • 1. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma.
    Izumi R; Shimizu K; Iyobe T; Ii T; Yagi M; Matsui O; Nonomura A; Miyazaki I
    Hepatology; 1994 Aug; 20(2):295-301. PubMed ID: 8045490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
    Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
    Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of postoperative recurrence of hepatocellular carcinoma by adjuvant locoregional chemotherapy].
    Izumi R; Shimizu K; Kiriyama M; Ii T; Iwasa K; Iyobe T; Masutani H; Yagi M; Miyazaki I; Matsui O
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1497-500. PubMed ID: 1326916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postoperative adjuvant arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma].
    Nakashima K; Aramaki M; Kawano K; Yoshida T; Kim YI; Kitano S; Kobayashi M
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1483-5. PubMed ID: 7574738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of postoperative recurrence after hepatic resection for metastatic colorectal cancer by adjuvant locoregional chemotherapy].
    Endo Y; Tani T; Kawaguchi A; Eguchi Y; Sano H; Kurumi Y; Hanasawa K; Ishibashi H; Terata N; Shibata J
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1535-7. PubMed ID: 8396906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of postoperative adjuvant arterial infusion chemotherapy in resected hepatoma patients].
    Nakashima K; Aramaki M; Yoshida T; Kim YI; Kitano S; Kobayashi M; Suzuki K; Aikawa H
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1481-4. PubMed ID: 8396901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant hepatic arterial infusion chemotherapy after radical hepatectomy for hepatocellular carcinoma--results of long-term follow-up.
    Asahara T; Itamoto T; Katayama K; Ono E; Dohi K; Nakanishi T; Kitamoto M; Azuma K; Ito K
    Hepatogastroenterology; 1999; 46(26):1042-8. PubMed ID: 10370664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Postoperative arterial infusion chemotherapy for hepatocellular carcinoma].
    Itamoto T; Asahara T; Okamoto Y; Nakahara H; Katayama K; Nomura S; Marubayashi S; Yahata H; Fukuda Y; Dohi K
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1493-6. PubMed ID: 1326915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative adjuvant locoregional chemotherapy in patients with hepatocellular carcinoma.
    Izumi R; Shimizu K; Miyazaki I
    Hepatogastroenterology; 1996; 43(12):1415-20. PubMed ID: 8975941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the effectiveness of adjuvant hepatic arterial chemotherapy after hepatectomy for primary or metastatic liver cancer].
    Isshiki K; Nonami T; Kishimoto W; Katoh H; Akaza K; Harada A; Nakao A; Takagi H
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1634-7. PubMed ID: 2167638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
    Lau WY; Lai EC; Leung TW; Yu SC
    Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.
    Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H
    Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of recurrent hepatocellular carcinoma after hepatic resection surviving over five years by hepatic arterial infusion of lipiodol-anticancer drug suspension].
    Takeda M; Mizuguchi N; Ohyama Y; Suzuki S; Itoh M; Mukojima T; Kumagai T; Iwasaki H
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1367-70. PubMed ID: 1648891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prophylactic chemotherapy by regional arterial infusion in resected hepatoma patients].
    Nakashima K; Kim YI; Okada K; Iwao Y; Aramaki M; Kobayashi M; Aikawa H; Suzuki K
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1489-92. PubMed ID: 1326914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
    Shiraishi R; Yamasaki T; Saeki I; Okita K; Yamaguchi Y; Uchida K; Terai S; Sakaida I
    Am J Clin Oncol; 2008 Aug; 31(4):311-6. PubMed ID: 18845987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of chemoembolization as an adjuvant therapy for primary liver carcinoma after surgical resection].
    Li JQ; Zhang YQ; Zhang WZ
    Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):387-9. PubMed ID: 7895595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
    Tabone M; Vigano' L; Ferrero A; Pellerito R; Carbonatto P; Capussotti L
    Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of hepatic arterial infusion chemotherapy on the prognosis after hepatectomy for hepatocellular carcinoma].
    Takagi K; Koyama T; Hasegawa M; Manabe K
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):597-600. PubMed ID: 9530370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transcatheter oily chemoembolization and intermittent hepatic artery infusion chemotherapy in the management of advanced hepatocellular carcinoma].
    Miura T; An M; Matsumoto Y; Terakado H; Murata M; Takagi S; Ikawa M; Hamada E; Watanabe K; Nakasato S
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1262-5. PubMed ID: 9703803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
    Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M;
    AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.